Literature DB >> 12153833

Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.

Joseph I Friedman1, Philip D Harvey, Susan R McGurk, Leonard White, Michael Parrella, Tenko Raykov, Thomas Coleman, David N Adler, Kenneth L Davis.   

Abstract

OBJECTIVE: Impairment in basic self-care skills is common in patients with schizophrenia and is even more severe in elderly patients with a chronic course of institutional care. While cognitive impairment has proven to be a major predictor of overall functional deficit in schizophrenia, other potential factors, such as medical comorbidity, need to be considered.
METHOD: Geriatric institutionalized schizophrenic patients (N=124) were assessed three times over 4 years to determine levels of positive and negative symptoms, impairment in activities of daily living, impairment in cognitive functioning, and medical problems. Path analysis was used to determine which variables best predicted changes in self-care functions.
RESULTS: Functional status, negative symptoms, cognitive functions, and health status all significantly worsened during the follow-up. The path analyses showed that change in health status did not predict change in activities of daily living after the analysis accounted for negative symptoms and cognitive functions. DISCUSSION: The results highlight the relative importance of cognitive impairments in the functional impairments of older schizophrenic patients with increased medical burden.

Entities:  

Mesh:

Year:  2002        PMID: 12153833     DOI: 10.1176/appi.ajp.159.8.1388

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  13 in total

1.  Will improving cognition change functional outcomes in schizophrenia?

Authors:  Philip D Harvey
Journal:  Psychiatry (Edgmont)       Date:  2007-04

Review 2.  Very poor outcome schizophrenia: clinical and neuroimaging aspects.

Authors:  Serge A Mitelman; Monte S Buchsbaum
Journal:  Int Rev Psychiatry       Date:  2007-08

Review 3.  Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies.

Authors:  Tarek K Rajji; Dielle Miranda; Benoit H Mulsant
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

Review 4.  Is there evidence for late cognitive decline in chronic schizophrenia?

Authors:  Jharna N Shah; Salah U Qureshi; Ali Jawaid; Paul E Schulz
Journal:  Psychiatr Q       Date:  2012-06

5.  Antipsychotic Adherence Intervention for Veterans over 40 with Schizophrenia: Results of a Pilot Study.

Authors:  Dinesh Mittal; Richard R Owen; Jonathan P Lacro; Pharm D; Reid D Landes; Mark Edlund; Marcia Valenstein; Dilip V Jeste
Journal:  Clin Schizophr Relat Psychoses       Date:  2009-01-01

6.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

7.  Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis.

Authors:  Joseph Ventura; Gerhard S Hellemann; April D Thames; Vanessa Koellner; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2009-07-22       Impact factor: 4.939

8.  Spondyloarthritis is associated with poor function and physical health-related quality of life.

Authors:  Jasvinder A Singh; Vibeke Strand
Journal:  J Rheumatol       Date:  2009-04-15       Impact factor: 4.666

9.  Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.

Authors:  Philip D Harvey; Cynthia O Siu; Steven Romano
Journal:  Psychopharmacology (Berl)       Date:  2003-11-13       Impact factor: 4.530

10.  Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophrenia.

Authors:  H Leutwyler; E Hubbard; D Jeste; B Miller; S Vinogradov
Journal:  Aging Ment Health       Date:  2014-04-04       Impact factor: 3.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.